efcsr Open Access Journal

European Frontiers in Current Science and Research

eISSN: Applied
Publication Frequency : 2 Issues per year.

  • Peer Reviewed & International Journal
Table of Content
Issues (Year-wise)
Loading…

Open Access iconOpen Access

ARTICLE

A FATAL CASE OF PNEUMOCEPHALUS LINKED TO HYPERMUCOVISCOUS, HYPRECLINICAL SAFETY ASSESSMENT OF EUPHORBIA HIRTA EXTRACTS: ACUTE AND SUBACUTE TOXICITY IN RODENT MODELS

1 Department of Pharmacology and Toxicology, Institute of Biomedical Sciences, University of Dodoma, Tanzania
2 Center for Natural Product Research, Faculty of Pharmacy, Universiti Teknologi Sarawak, Malaysia
3 Division of Toxicological Studies, Indian Institute of Experimental Medicine, Bhubaneswar, Odisha, India

Citations: Loading…
ABSTRACT VIEWS: 39   |   FILE VIEWS: 69   |   PDF: 69   HTML: 0   OTHER: 0   |   TOTAL: 108
Views + Downloads (Last 90 days)
Cumulative % included

Abstract

Euphorbia hirta, a widely used medicinal plant, holds significant traditional and pharmacological importance. This study aimed to evaluate the acute and subacute oral toxicity of Euphorbia hirta methanol extract in mice and Wistar rats, respectively. In the acute toxicity study, single oral doses up to 5000 mg/kg in mice caused no mortality or significant clinical signs, indicating a low acute toxicity profile (LD50 > 5000 mg/kg). For the subacute study, Wistar rats received daily oral doses of 250, 500, or 1000 mg/kg for 28 days. No significant changes were observed in body weight, organ weights, food/water intake, hematological parameters (RBC, WBC, Hb, PCV, platelets), or biochemical markers of liver (ALT, AST, ALP) and kidney (creatinine, urea) function across all treated groups compared to controls. Histopathological examination of vital organs (liver, kidneys, spleen, heart, lungs, brain) also revealed no morphological alterations. These findings suggest that Euphorbia hirta methanol extract has a favorable safety profile with no significant systemic or organ-specific toxicity at the tested doses, supporting its traditional use and potential for therapeutic development.


Keywords

Euphorbia hirta, acute toxicity, subacute toxicity, preclinical safety

References

1. Sulieman, A. M. E. (2024). General Terms of Toxicology. In Microbial Toxins in Food Systems: Causes, Mechanisms, Complications, and Metabolism (pp. 11-24). Cham: Springer Nature Switzerland.

2. World Health Organization (WHO). (2013). Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. WHO Press.

3. Kokova, V. (2023). METHODS FOR DETERMINING SUB-ACUTE, SUB-CHRONIC, AND CHRONIC TOXICITY OF CHEMICAL COMPOUNDS. KNOWLEDGE-International Journal, 59(4), 257-261.

4. Heinrich, M., Jalil, B., Abdel-Tawab, M., Echeverria, J., Kulić, Ž., McGaw, L. J., ... & Wang, J. B. (2022). Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research—the ConPhyMP—guidelines. Frontiers in Pharmacology, 13, 953205.

5. Tripathi, A. N., Sati, S. C., & Kumar, P. (2021). Euphorbia hirta Linn-an invasive plant: A review of its traditional uses, phytochemistry and pharmacological properties. System, 17, 22.


How to Cite

Dr. Kembah A. Rodalle, Dr. Melvia N. Ikrawan, & Dr. Tharun J. Belmika. (2024). A FATAL CASE OF PNEUMOCEPHALUS LINKED TO HYPERMUCOVISCOUS, HYPRECLINICAL SAFETY ASSESSMENT OF EUPHORBIA HIRTA EXTRACTS: ACUTE AND SUBACUTE TOXICITY IN RODENT MODELS. European Frontiers in Current Science and Research, 1(01), 41-52. https://parthenonfrontiers.com/index.php/efcsr/article/view/171

Share Link